The LiquiBand® XL system provides safe, secure, and effective closure for large and high-tension wounds.([FOOTNOTE=Pre-Clinical Safety & Performance Eval Porcine Model 14 Days Section 16.1 and 16.2. May 2021.],[ANCHOR=],[LINK=]),([FOOTNOTE=Based on AMS report #005-156. LiquiBand® XL Clinical Evaluation Report. Section 9.2 and 10. February 2021.],[ANCHOR=],[LINK=]),† With its octyl-based cyanoacrylate formulation, LiquiBand® XL has a number of advantages, including:
But the benefits don't stop there. Review the above resources for more information.
LiquiBand® Exceed™ is a 2-octyl-cyanoacrylate topical skin adhesive. With 30 cm of linear coverage per vial,([FOOTNOTE=Based on internal report #001–466, Project Fal wound length claim verification report. January 6, 2015.],[ANCHOR=],[LINK=]) it requires up to three times less volume of adhesive to close the same length of wound as Dermabond Advanced™*.([FOOTNOTE=Based on internal report #000-558, Wound burst strength testing summary and executive statement. July 2015.],[ANCHOR=],[LINK=]) Its clog-free applicator([FOOTNOTE=Based on internal report #001–467, Project Fal intraoperative reuse verification report. January 2015.],[ANCHOR=],[LINK=]) means it can be used – and re-used – for up to 90 minutes of intra-operative time.5,7,([FOOTNOTE=Based on internal report #003–219, Design verification report: Expressive yield average of adhesive application. September 2018.],[ANCHOR=],[LINK=]),([FOOTNOTE=Based on internal report #001–309, Design verification report: Project Fal DI 34. September 2014.],[ANCHOR=],[LINK=])
LiquiBand® Exceed™ topical skin adhesive is ideal for medium to long surgical incisions.
LiquiBand® Exceed™ XS is a 2-octyl-cyanoacrylate topical skin adhesive. With 7 cm of linear coverage8 in a clog-free applicator7, it can be used— and re-used —for up to 90 minutes of intra-operative time.9,7,8,9
LiquiBand® Exceed™ XS topical skin adhesive is an ideal solution for small incisions and laparoscopic port closures.
SwiftSet™ is a butyl cyanoacrylate topical skin adhesive with a 30-second dry time and unique precision tip attachment.
Do not use on any wounds with evidence of infection, gangrene, or on wounds of decubitus etiology. Do not use on mucosal surfaces or across mucocutaneous junctions, or skin that may be regularly exposed to body fluids or with dense nature hair. Adverse effects include but not limited to infection, acute inflammation include erythema, edema, and drainage, wound dehiscence, bleeding, skin edge necrosis. Please refer to IFU for complete contraindication and risk information.
©2022 Medtronic. Medtronic, Medtronic logo and Engineering the extraordinary are trademarks of Medtronic. LiquiBand® is a registered trademark of Advanced Medical Solutions Ltd. All other brands are trademarks of a Medtronic company.
†Tension should be mitigated prior to application according to product IFU. Based on AMS pre-clinical data, may not be indicative of clinical performance.
‡Based on AMS pre-clinical data, may not be indicative of clinical performance.
§Based on AMS bench testing data, may not be indicative of clinical performance.
ΩStudy demonstrates that LiquiBand® XL™ holds when subject has light daily activity. Based on AMS pre-clinical data, may not be indicative of clinical performance.
††Compared to Dermabond® Prineo®. Based on AMS bench testing data, may not be indicative of clinical performance.
‡‡LiquiBand® XL is intended for topical application only to hold closed easily approximated skin edges of wounds from surgical incisions, and simple thoroughly cleansed, trauma-induced lacerations.